Why doctors are rethinking breast-cancer treatment

Thanks to advances in genomic testing and deeper insights into the biology of different kinds of breast cancer, doctors are learning that the one-size-fits-all approach isn’t working. They’re also learning that every woman brings with her a unique profile of biological risk—as well as a unique appetite for risk. Mehra Golshan (Brigham and Women’s) is quoted.

Read the full article